- Home
- PMT vs PVLA Comparison
PMT vs PVLA Comparison
Compare PMT & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMT | PVLA |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMT | PVLA |
|---|---|---|
| Price | $13.09 | $92.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 17 |
| Target Price | $14.13 | ★ $145.24 |
| AVG Volume (30 Days) | ★ 1.2M | 319.0K |
| Earning Date | 01-29-2026 | 11-11-2025 |
| Dividend Yield | ★ 12.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $564,655,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.66 | N/A |
| P/E Ratio | $13.92 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.60 | $12.02 |
| 52 Week High | $14.93 | $114.69 |
Technical Indicators
Market Signals| Indicator | PMT | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 58.29 | 48.25 |
| Support Level | $12.33 | $82.38 |
| Resistance Level | $12.72 | $105.54 |
| Average True Range (ATR) | 0.25 | 8.86 |
| MACD | -0.00 | -1.24 |
| Stochastic Oscillator | 64.90 | 35.96 |
Price Performance
Historical ComparisonAbout PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.